
Friday, September 13, 2013 2:53:07 AM
Recent ACAD News
- Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 02/14/2025 09:05:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/14/2025 02:00:06 PM
- Acadia Pharmaceuticals to Announce Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025 • Business Wire • 02/12/2025 09:05:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/07/2025 11:04:20 AM
- Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 01/17/2025 09:05:00 PM
- Acadia Pharmaceuticals Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare Conference • Business Wire • 01/14/2025 02:05:00 PM
- Acadia Pharmaceuticals Set to Join S&P SmallCap 600 • PR Newswire (US) • 12/30/2024 10:37:00 PM
- Acadia Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 14, 2025 • Business Wire • 12/19/2024 09:05:00 PM
- Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 12/16/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2024 09:22:29 PM
- Acadia Pharmaceuticals Announces Closing of Sale of Rare Pediatric Disease Priority Review Voucher for $150 Million • Business Wire • 12/11/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/10/2024 11:33:31 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 12/10/2024 11:31:19 PM
- Acadia Pharmaceuticals Appoints Thomas Garner Chief Commercial Officer • Business Wire • 12/09/2024 02:00:00 PM
- Acadia Pharmaceuticals Announces Exclusive License Agreement with Saniona for SAN711 • Business Wire • 11/26/2024 09:05:00 PM
- Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences • Business Wire • 11/21/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2024 09:30:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/20/2024 01:43:42 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/20/2024 01:41:52 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/20/2024 01:40:08 AM
- Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 11/15/2024 09:05:00 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/14/2024 11:48:52 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2024 09:14:26 PM
- Acadia Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operating Overview • Business Wire • 11/06/2024 09:05:00 PM
- Acadia Pharmaceuticals Enters Into an Agreement to Sell its Rare Pediatric Disease Priority Review Voucher for $150 Million • Business Wire • 11/05/2024 09:05:00 PM
YCRM ReachOut Technology Returns to Trading: CEO Rick Jordan Lays Out Blockchain CyberSecurity Strategy and Industry-First AI MSP Partnership In Shareholder Letter • YCRM • Feb 18, 2025 11:20 AM
VAYK Confirms No Dilution Following Recent Acquisition and 11 Million Insider Purchase • VAYK • Feb 18, 2025 9:30 AM
UAV Corp. (OTC: UMAV) Announces Nationwide Teleconference to Provide Shareholders with Key Updates on Contracts, Future Plans, and Share Structure • UMAV • Feb 18, 2025 8:30 AM
COEPTIS Announces the Launch of COEP Venture Group to Invest in AI, RPA, and AI Agent Startups • COEP • Feb 13, 2025 9:10 AM
Unitronix Corp. to Report Over 300% Gains in Cryptocurrency Assets • UTRX • Feb 13, 2025 7:15 AM
Hivello Token ($HVLO) now Live • MATE • Feb 11, 2025 9:27 AM